Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: Reinstatement of the booster dose at ages 12-15 months

Morbidity and Mortality Weekly Report

Volumn 58, Issue 24, 2009, Pages 673-674

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS VACCINE;

ARTICLE; DRUG CONTROL; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; INFANT; UNITED STATES;

DRUG AND NARCOTIC CONTROL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; UNITED STATES;

EID: 67649236758     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. CDC. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax). MMWR 2007;56:1318-20.
2. CDC. Continued shortage of Haemophilus influenzae type b (Hib) conjugate vaccines and potential implications for Hib surveillance-United States, 2008. MMWR 2008;57:1252-5.
3. American Academy of Pediatrics. Haemophilus influenzae infections. In: Pickering LK, Baker CJ, Kimberlin CW, Long SS, eds. Red book: 2009 report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:314-21.
4. CDC. Invasive Haemophilus influenzae type b disease in five young children-Minnesota, 2008. MMWR 2009;58:58-60.
5. CDC health advisory. Invasive Haemophilus influenzae type b disease in young children and importance for all young children to receive 3 dose primary series with available Hib-containing vaccine. Available at http://www2a.cdc.gov/han/archivesys/viewmsgv.asp?alertnum=00281